ARMISTICE CAPITAL LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 1,000,000 4.720% | -1,064,000 (-51.55%) | Filing |
| 2024-02-14 2:26 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 2,064,000 9.800% | -14,000 (-0.67%) | Filing |
| 2023-02-14 12:39 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 2,078,000 9.990% | 1,022,000 (+96.78%) | Filing |
| 2022-02-14 6:31 pm Unchanged | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 1,056,000 5.100% | 0 (Unchanged) | Filing |
| 2022-02-14 5:14 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 1,056,000 5.100% | -300,000 (-22.12%) | Filing |
| 2021-02-16 5:05 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 1,356,000 6.700% | 1,356,000 (New Position) | Filing |